JoanaMRibeiro2

Médica.Curiosa...por tudo.

[Harold J. Burstein, MD, PhD, FASCO @DrHBurstein]

Have a look at our @JCO_ASCO editorial written with @ThomasGrinda from @GustaveRoussy including table at end.
Did we get it right?

Anthracyclines in Early Breast Cancer: The Long Goodbye | Journal of Clinical Oncology https://t.co/yUqbWinSqW

[JoanaMRibeiro2 @Ribeiro2M]

Very nice discussions about almost every aspect you can think about in BC management! @hoperugo , @valentinaguarneri, @stephenchia, @carlosbarrios! @metebalfoheidi!

[Gustave Roussy @GustaveRoussy]

@BenjaminBesseMD @dplanchard @barlesi @myESMO @PBlanchardMD @ines_vazluis 🔹 OPT-PEMBRO trial led by Dr Joana Ribeiro @GustaveRoussy is a model of tailored perioperative trial in Breast Cancer highlighted at #ESMO24 Presidential Session.
@Ribeiro2M @myESMO

[MarleenKokLab @lab_kok]

👏👏👏 for @MyriamChalabi and NICHE2 team @NKI_nl. The KM ‘curve’ doesnt apply here its a line ate 100% survival, unprecedented! Congrats!

[Mafalda Oliveira @MOliveira_MD]

What is the impact of immune checkpoint inhibitors in the outcome of patients with early breast cancer? Check out this huge work led by @G_Villacampa and @TomasPascualMD
Treatment tailoring is paramount to improve patient care!
@myESMO @OncoAlert @VHIO @ASCO

[MarleenKokLab @lab_kok]

Thanks @DFCI_BreastOnc for highlighting our recent Commentary paper @JCO_ASCO

[MarleenKokLab @lab_kok]

1/1 Today ✍️ @JCO_ASCO Sometimes treating TNBC can be challenging. Nowadays, academic clin res to improve treatm for TNBC can also be challenging. How do we get from one-size fits all with 4 types of chemo plus 1yr of pembro to a personalized treatm?
https://t.co/vdiq6ubyeY

[JoanaMRibeiro2 @Ribeiro2M]

Waiting for the olympic flame.....

[MarleenKokLab @lab_kok]

Congrats @VeerleGeurts and @TILsWorkGroup. Why is this @JAMAOnc paper important? Its known that TILs are progn in TNBC and that not all stage I TNBC pts benefit from chemo.👇we show that pT1cN0 pts with high TILs have excel survival without chemo! @NKI_nl

[JoanaMRibeiro2 @Ribeiro2M]

@PTarantinoMD @NicoleKuderer @stolaney1 What a great team!!!

[Nuno Rogeiro @nrogeiro @nrogeiro]

Ao cuidado das ovelhas e carneiros de todo o mundo

[JoanaMRibeiro2 @Ribeiro2M]

After last night elections....

[Nadia Harbeck,MD PhD @Prof_Nadia_H]

Chairing an Oxford discussion on Ki67 at the Annual German Senology Conference. Amazing to see that about 70% of the breast centers use endocrine response assessment in clinical routine according to WSG ADAPT. #OncoAlert

[JoanaMRibeiro2 @Ribeiro2M]

@pauloprata Felizmente ainda podemos...eu voto para não perder esse privilégio! Bisous

[JoanaMRibeiro2 @Ribeiro2M]

Dia de eleições! Para os portugueses em Paris, muito fácil votar no consulado! Até 19h basta o cartão cidadão!!!

[European Commission @EU_Commission]

🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺 V 🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺 O 🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺 T 🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺 E 🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺

#UseYourVote

[European Commission @EU_Commission]

🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺 V 🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺 O 🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺 T 🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺 E 🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺

#UseYourVote

[JoanaMRibeiro2 @Ribeiro2M]

Another #ESMObreast24...Another science productive and awarded year for BreastUnit_DMO @GustaveRoussy @GR_SurvOnc team! @BarbaraPistill2 Suzette delaloge @ElieRassy @JZeghondi @fedgiugliano @GrindaThomas @ines_vazluis @J_DixonDouglas @FerMosele @dimeglio_anto @marti_pagliuca

[Franzoi Maria Alice @AliceFranzoi]

We are so lucky to have you as a mentor @ines_vazluis congratulations 🎉🎉⭐️

[BREAST CANCER CONNECT powered by COR2ED @BreastCaConnect]

💭Ultra-short treatments offer promising avenues for improving cancer care efficiency. While challenges persist, such as personalisation & innovative trial designs, the potential benefits for patients are significant.

An interesting editorial: https://t.co/DKYTa2esxJ

#MedEd

[Julia Dixon-Douglas @J_DixonDouglas]

@ESMO_Open @FAndreMD @Ribeiro2M